1. South Korea Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Yuyu Pharma, Inc.

Yuyu Pharma, Inc.

000227.KS
Yuyu Pharma, Inc.KR flagKorea Exchange
8,810.00
KRW
-60.00
- -
59.51BMarket Cap

Total Valuation

Yuyu Pharma, Inc. carries a market capitalization of 59.51B, placing it among publicly traded companies globally. Its enterprise value stands at 10.44B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap59.51B
Enterprise Value10.44B

Share Statistics

Yuyu Pharma, Inc. currently has 15.75M shares outstanding.

Shares Outstanding15.75M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Enterprise Valuation

On an enterprise value basis, Yuyu Pharma, Inc. trades at an EV/EBITDA multiple of 0.92 and an EV/FCF ratio of 0.38. The EV/Sales ratio of 0.07 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 0.92 provides insight into valuation relative to core operating earnings.

EV / Sales0.07
EV / EBITDA0.92
EV / EBIT0.92
EV / FCF0.38

Financial Position

Yuyu Pharma, Inc. maintains a current ratio of 1.68, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.39, indicating elevated leverage, while an interest coverage ratio of 5.11 demonstrates adequate ability to service its debt obligations.

Current Ratio1.68
Quick Ratio0.53
Debt / Equity18.39
Debt / EBITDA2.30
Interest Coverage5.11

Financial Efficiency

Yuyu Pharma, Inc. posts a return on equity of 18.97 and a return on invested capital of 6.37.

Return on Equity (ROE)18.97
Return on Assets (ROA)4.34
Return on Invested Capital (ROIC)6.37
Return on Capital Employed (ROCE)11.77
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.26

Taxes

Over the trailing twelve months, Yuyu Pharma, Inc. has paid 535.53M in income taxes, reflecting an effective tax rate of 5.35.

Income Tax535.53M
Effective Tax Rate5.35

Stock Price Statistics

Yuyu Pharma, Inc.'s stock has declined approximately -16.49289% over the past 52 weeks. The 50-day moving average sits at 10,434.80, while the 200-day moving average is 10,658.65.

Beta (5Y)N/A
52-Week Price Change-16.49289%
50-Day Moving Average10,434.80
200-Day Moving Average10,658.65
Average Volume (20 Days)N/A

Income Statement

EBITDA reached 11.41B, while operating income came in at 11.41B.

Revenue143.52B
Gross Profit54.80B
Operating Income11.41B
Pretax Income10.00B
Net Income9.05B
EBITDA11.41B
EBIT11.41B
Earnings Per Share (EPS)N/A

Balance Sheet

Yuyu Pharma, Inc. holds 29.89B in cash and equivalents against 26.21B in total debt, resulting in a net debt position of -777.50M. Total book value stands at 51.42B, with working capital of 38.29B providing operational flexibility.

Cash & Cash Equivalents29.89B
Total Debt26.21B
Net Debt-777.50M
Equity (Book Value)51.42B
Book Value Per ShareN/A
Working Capital38.29B

Cash Flow

Yuyu Pharma, Inc. produced 15.02B in operating cash flow over the past twelve months.

Operating Cash Flow15.02B
Capital Expenditures-10.69B
Free Cash Flow4.34B
FCF Per ShareN/A

Margins

Yuyu Pharma, Inc. operates with a gross margin of 38.18, reflecting its pricing power and cost economics. The operating margin of 7.95 and net profit margin of 6.31 provide insight into operational efficiency.

Gross Margin38.18
Operating Margin7.95
Pretax Margin6.97
Profit Margin6.31
EBITDA Margin7.95

Stock Splits

Yuyu Pharma, Inc.'s most recent stock split took place on March 30, 2021 with a 1:2 split ratio.

Last Split Date3/30/2021
Split Ratio1:2

Scores

Yuyu Pharma, Inc. posts an Altman Z-Score of 1.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.34